Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants
about
Phthalates and other additives in plastics: human exposure and associated health outcomesEndocrine-disrupting chemicals: an Endocrine Society scientific statementImpact of hospital-based environmental exposures on neurodevelopmental outcomes of preterm infantsExposure to environmental endocrine disruptors and child developmentResearch opportunities in optimizing storage of red blood cell productsPhthalate exposure and children's healthMechanisms mediating environmental chemical-induced endocrine disruption in the adrenal glandPredictors of urinary bisphenol A and phthalate metabolite concentrations in Mexican childrenDo Thyroid Disrupting Chemicals Influence Foetal Development during Pregnancy?The adverse cardiac effects of Di(2-ethylhexyl)phthalate and Bisphenol APlastics, the environment and human health: current consensus and future trendsIatrogenic environmental hazards in the neonatal intensive care unit.Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study.In utero exposure to the endocrine disruptor di-(2-ethylhexyl) phthalate promotes local adipose and systemic inflammation in adult male offspring.A critical assessment of the endocrine susceptibility of the human testis to phthalates from fetal life to adulthood.Influence of polyvinyl chloride infusion extension tube on propofol injection pain: a randomised controlled study.A review of alternatives to di (2-ethylhexyl) phthalate-containing medical devices in the neonatal intensive care unitThe association between phthalates in dust and allergic diseases among Bulgarian children.Exposure to phthalates among premenstrual girls from rural and urban Gharbiah, Egypt: a pilot exposure assessment studyExposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolitesDiverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property?Prenatal Exposure to Endocrine Disruptors: A Developmental Etiology for Polycystic Ovary Syndrome.Altered Hippocampal Lipid Profile Following Acute Postnatal Exposure to Di(2-Ethylhexyl) Phthalate in RatsPeroxisome proliferator-activated receptors as mediators of phthalate-induced effects in the male and female reproductive tract: epidemiological and experimental evidenceNon-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses.Phthalates in food and medical devices.Phthalate concentrations and dietary exposure from food purchased in New York StateExposure to bisphenol A and other phenols in neonatal intensive care unit premature infants.Hidden Toxicity in Neonatal Intensive Care Units: Phthalate Exposure in Very Low Birth Weight InfantsReproductive and developmental toxicity of phthalates.Phthalates in the NICU: is it safe?Phthalates and critically ill neonates: device-related exposures and non-endocrine toxic risks.Circulating phthalates during critical illness in children are associated with long-term attention deficit: a study of a development and a validation cohort.PLASTICS AND CARDIOVASCULAR HEALTH: PHTHALATES MAY DISRUPT HEART RATE VARIABILITY AND CARDIOVASCULAR REACTIVITY.Analysis of toxicity effects of Di-(2-ethylhexyl) phthalate exposure on human bronchial epithelial 16HBE cells.Phthalates in neonatal health: friend or foe?Ultrasound gel as an unrecognized source of exposure to phthalates and phenols among pregnant women undergoing routine scan.DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities.Pubertal exposure to di-(2-ethylhexyl)-phthalate inhibits G9a-mediated histone methylation during spermatogenesis in mice.Role of phospholipase D in regulation of testicular Leydig cell hyperplasia in Sprague-Dawley rats treated with di(2-ethylhexyl) phthalate.
P2860
Q24611244-747AEF5D-7472-4DBE-BC8E-2BF4988256C1Q24651457-0F3E01C9-7D92-4260-8A79-2268870476B7Q27012399-BB188327-466E-484C-8733-87F7D57A7B38Q27012530-50479CBD-10F1-456B-BF37-F8C79203B4A8Q27023101-4D9C851D-A0FE-4CE5-BB0F-F847F6F7BEAFQ28387495-4510FFB4-463B-4720-B640-4C9D3AF9DE5CQ28389245-49FEAE64-54D1-415A-AB79-37C500CC45D5Q28390598-2F3DDEAF-E6B6-4623-BBA6-570099AC2ACFQ28391841-B3EE74E6-3CFF-4D6A-987D-34155EB6113FQ28396757-6A56D026-DFD7-414A-9C2A-1AB1AD365461Q28752073-40A89F15-246C-46FD-B2F9-5F5D331AFE92Q30473743-D5F4DB84-8FD4-4D11-9DF2-5C12E0ED2925Q31077492-D98A2AA0-5464-4100-8ABA-F9B62BF0C1A7Q33702204-E833DCEA-6EA1-4BF8-A447-43E1AE47C1E4Q34374172-7CA4F62A-2D9A-42D8-9D3A-14C2FF98FC65Q34488923-9ED10F72-01D2-4E29-B639-8F3727F2A41BQ34626917-38E43618-02ED-4E54-8988-4C7284D3D878Q34736449-E6552218-233D-4308-B932-5DBE60B7FEF8Q35038388-F3628B5C-0E82-4B70-B055-028B7ED65563Q35039257-20BC999D-12B7-46DD-B7BC-001377CC1388Q35653376-5A07DB18-E2DD-47BF-AA2C-AEF6A34CFECFQ36061330-4C9850CB-167B-4FD8-AFD6-9198FB7F2AB2Q36227952-A207ACB6-5DF8-42BA-AB68-7C7CB72F3CB8Q36426777-65846B39-EAA9-4422-A203-33791F752B5BQ36526705-2B6BBBFC-0D43-490E-8AEB-317DDDEE8622Q36548747-2138C38C-10C3-4F3B-9D26-975CED955719Q36749724-0E42013C-2B76-4456-BB4F-66F0C90D3418Q37185633-E75943A5-F4D3-4D03-A99B-5628D9355758Q37395128-DCBF6348-60FF-4754-83FE-D68AC9FA4C06Q37698399-E702CBE8-92C4-49A5-84A0-DEE6B76AC55BQ38109996-FCA1CA0B-DC67-484E-9391-7F1A51F4D3D9Q38263935-A69D3D08-DB4D-4682-A39D-ADC0473AD5BCQ38398460-EA8C1E43-A6AF-42C6-8021-5475A2962E56Q38637164-8292FA85-136F-4247-A012-6FE3B706039AQ38697794-205C300C-311A-4154-9F59-2E63822CA640Q38884992-DE4BF76A-C2A3-4A61-A8CC-F76E8127B71BQ40074859-6B75BE3B-4C9F-4FBF-BBCE-9BD3A38EE944Q40173707-642C1A8C-AB1E-4468-98ED-F994FF4A8FC6Q40938439-FD00AA7F-7B23-46FC-9280-5A272EF302C4Q42810843-271D8755-6D67-4990-BD90-FB785297CE54
P2860
Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@ast
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@en
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@nl
type
label
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@ast
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@en
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@nl
prefLabel
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@ast
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@en
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Use of di(2-ethylhexyl) phthal ...... al intensive care unit infants
@en
P2093
Kenneth Huttner
Ronald Green
Steven Ringer
Ted Schettler
P2860
P2880
P304
P3181
P356
10.1289/EHP.7932
P407
P577
2005-09-01T00:00:00Z